Phibro Animal Health Corp. (PAHC)
34.87
-0.15
(-0.43%)
USD |
NASDAQ |
Nov 17, 16:00
34.87
0.00 (0.00%)
After-Hours: 19:36
Phibro Animal Health Enterprise Value : 2.128B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 2.128B |
| November 13, 2026 | 2.166B |
| November 12, 2026 | 2.146B |
| November 11, 2026 | 2.133B |
| November 10, 2026 | 2.112B |
| November 09, 2026 | 2.111B |
| November 06, 2026 | 2.044B |
| November 05, 2026 | 2.143B |
| November 04, 2026 | 2.307B |
| November 03, 2026 | 2.235B |
| November 02, 2026 | 2.279B |
| October 30, 2026 | 2.285B |
| October 29, 2026 | 2.284B |
| October 28, 2026 | 2.244B |
| October 27, 2026 | 2.264B |
| October 26, 2026 | 2.291B |
| October 23, 2026 | 2.281B |
| October 22, 2026 | 2.322B |
| October 21, 2026 | 2.300B |
| October 20, 2026 | 2.281B |
| October 19, 2026 | 2.303B |
| October 16, 2026 | 2.282B |
| October 15, 2026 | 2.248B |
| October 14, 2026 | 2.246B |
| October 13, 2026 | 2.201B |
| Date | Value |
|---|---|
| October 12, 2026 | 2.226B |
| October 09, 2026 | 2.261B |
| October 08, 2026 | 2.225B |
| October 07, 2026 | 2.237B |
| October 06, 2026 | 2.192B |
| October 05, 2026 | 2.216B |
| October 02, 2026 | 2.218B |
| October 01, 2026 | 2.162B |
| September 30, 2026 | 2.157B |
| September 29, 2026 | 2.145B |
| September 28, 2026 | 2.155B |
| September 25, 2026 | 2.104B |
| September 24, 2026 | 2.083B |
| September 23, 2026 | 2.090B |
| September 22, 2026 | 2.133B |
| September 21, 2026 | 2.114B |
| September 18, 2026 | 2.109B |
| September 17, 2026 | 2.104B |
| September 16, 2026 | 2.139B |
| September 15, 2026 | 2.128B |
| September 14, 2026 | 2.165B |
| September 11, 2026 | 2.152B |
| September 10, 2026 | 2.191B |
| September 09, 2026 | 2.200B |
| September 08, 2026 | 2.220B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Becton, Dickinson & Co. | 74.29B |
| Globus Medical, Inc. | 8.944B |
| Zoetis, Inc. | 42.09B |
| IDEXX Laboratories, Inc. | 55.98B |
| Corcept Therapeutics, Inc. | 7.209B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 29.52M |
| Revenue (Quarterly) | 386.77M |
| Total Expenses (Quarterly) | 357.25M |
| EPS Diluted (Quarterly) | 0.7208 |
| Gross Profit Margin (Quarterly) | 33.04% |
| Profit Margin (Quarterly) | 7.63% |
| Earnings Yield | 7.19% |
| Operating Earnings Yield | 14.21% |
| Normalized Earnings Yield | 8.145 |